(Q57240752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Leukotrienes as mediators of airway obstruction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

JEFFREY M. DRAZEN

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5 Pt 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

S193-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotriene D: a slow reacting substance from rat basophilic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spas

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Identification of the C(6)-S-conjugate of leukotriene a with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

THE LIBERATION OF A SLOW-REACTING SMOOTH MUSCLE-STIMULATING SUBSTANCE IN ANAPHYLAXIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effects of Intravenous Administration of Slow-Reacting Substance of Anaphylaxis, Histamine, Bradykinin, and Prostaglandin F2α on Pulmonary Mechanics in the Guinea Pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Phospholipases in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

The role of phospholipases and phosphoIipid-derived signals in cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

5-lipoxygenase-activating protein is an arachidonate binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Molecular cloning and amino acid sequence of human 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Photoaffinity labelling and radiation inactivation of the leukotriene B4 receptor in human myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Identification and characterization of leukotriene D4 receptors in adult and fetal human lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

The signal transduction system of the leukotriene D4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

(Phenylmethoxy)phenyl derivatives of w-oxo- and w-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

BAY u9773--an LTC4 antagonist in the guinea pig trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotrienes and airway responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Inhalation challenge with sulfidopeptide leukotrienes in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Antileukotrienes in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Identification and isolation of a membrane protein necessary for leukotriene production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.SUPPLEMENT_2.13TAC180

10.1164/AJRCCM.158.SUPPLEMENT_2.13TAC180

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9817745%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference